» Articles » PMID: 22245830

Saturated Fatty Acid Exposure Induces Androgen Overproduction in Bovine Adrenal Cells

Overview
Journal Steroids
Publisher Elsevier
Specialty Biochemistry
Date 2012 Jan 17
PMID 22245830
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Polycystic ovary syndrome (PCOS) is mainly defined by hyperandrogenemia, from ovarian and adrenal origin, and is characterized by insulin resistance (IR). Studies found that raising in vivo non-esterified fatty acid (NEFA) levels, which induces lipotoxicity, increases androgen levels and IR. The aim of this study was therefore to determine the effects of in vitro over-exposure to NEFA on androgen synthesis in a bovine adrenocortical cell model.

Methods: Bovine fasciculata/reticularis cells were cultured for 2days in the absence or presence of ACTH (10nmol/L) or Forskolin (fsk, 10μmol/L), alone or in combination with the saturated fatty acid (FA) palmitate (100μmol/L). Steroid production was measured in medium and corrected for initial cell seeding count. CYP17 protein expression and ERK1/2 phosphorylation were assessed by Western blotting.

Results: Under unstimulated conditions, dehydroepiandrosterone (DHEA) levels were barely detected and no difference was observed after palmitate exposure, which was also the case for CYP17 expression and ERK1/2 phosphorylation. Under stimulation, palmitate exposure increased DHEA production by 38% and 69%, for ACTH and fsk, respectively, as compared to untreated conditions (Ps⩽0.05). In palmitate-treated vs untreated cells, fsk-stimulated ERK1/2 phosphorylation was reduced by 46% (P=0.0047), but stimulated CYP17 expression was not significantly affected.

Conclusion: In a model of androgen-producing cells, under stimulated conditions, overexposure to saturated FAs significantly increases androgen production and reduces MEK/ERK activation. Therefore, this study is the first to demonstrate that lipotoxicity can directly trigger androgen overproduction in vitro, in addition to its well-described impact on IR, which strongly supports a central role of lipotoxicity in PCOS pathophysiology.

Citing Articles

Prevalence of Polycystic Ovary Syndrome in Patients With Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.

Cioana M, Deng J, Nadarajah A, Hou M, Qiu Y, Chen S JAMA Netw Open. 2022; 5(2):e2147454.

PMID: 35166782 PMC: 8848210. DOI: 10.1001/jamanetworkopen.2021.47454.


The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms.

Jiang N, Li X Reprod Sci. 2021; 29(9):2465-2476.

PMID: 34046867 DOI: 10.1007/s43032-021-00629-9.


Normal and Premature Adrenarche.

Rosenfield R Endocr Rev. 2021; 42(6):783-814.

PMID: 33788946 PMC: 8599200. DOI: 10.1210/endrev/bnab009.


Do Dehydroepiandrosterone (DHEA) and Its Sulfate (DHEAS) Play a Role in the Stress Response in Domestic Animals?.

Gabai G, Mongillo P, Giaretta E, Marinelli L Front Vet Sci. 2020; 7:588835.

PMID: 33195624 PMC: 7649144. DOI: 10.3389/fvets.2020.588835.


Non-esterified fatty acids in the ovary: friends or foes?.

Baddela V, Sharma A, Vanselow J Reprod Biol Endocrinol. 2020; 18(1):60.

PMID: 32505200 PMC: 7275390. DOI: 10.1186/s12958-020-00617-9.


References
1.
Nelson-Degrave V, Wickenheisser J, Hendricks K, Asano T, Fujishiro M, Legro R . Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol. 2004; 19(2):379-90. DOI: 10.1210/me.2004-0178. View

2.
Ehrmann D, Schneider D, Sobel B, Cavaghan M, Imperial J, Rosenfield R . Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997; 82(7):2108-16. DOI: 10.1210/jcem.82.7.4069. View

3.
Boden G . Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011; 18(2):139-43. PMC: 3169796. DOI: 10.1097/MED.0b013e3283444b09. View

4.
Baillargeon J, Nestler J . Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?. J Clin Endocrinol Metab. 2005; 91(1):22-4. PMC: 3846532. DOI: 10.1210/jc.2005-1804. View

5.
Nestler J, Jakubowicz D . Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996; 335(9):617-23. DOI: 10.1056/NEJM199608293350902. View